EGFR Mutation Analysis is a molecular diagnostic test used to detect mutations in the Epidermal Growth Factor Receptor (EGFR) gene, most commonly in non-small cell lung cancer (NSCLC). This test helps identify clinically significant mutations in exons 18, 19, 20, and 21 of the EGFR gene that may predict response or resistance to EGFR tyrosine kinase inhibitor (TKI) targeted therapy such as erlotinib, gefitinib, afatinib, osimertinib, and other targeted agents. EGFR mutation testing is commonly performed on tumor tissue or cytology specimens and is essential for personalized cancer treatment planning, prognosis assessment, and therapy selection in patients with suspected or confirmed lung adenocarcinoma or advanced NSCLC. It is an important precision oncology test that guides oncologists in selecting the most effective targeted treatment strategy.
Fasting
Not Required
Reporting Time
7–10 Days
Gender
Male/Female
Age Group
All Age Group
✔ Home collection available ✔ No hidden charges
Need help? Call 1800-123-4567
Kidney / Renal | Heart & Cardiac Health | Liver Test | Comprehensive Diabetes | Comprehensive Thyroid | Child & Adolescent Health | Women's Health | Men's Health | Cancer | Immunity & Allergy Test | Fever & Infection | Pancreas | Vitamins & Nutrition | Sexual Wellness/STDs | Bone & Joint Health | Hormonal | Urine & Stool Test | Infectious Diseases | Covid & Respiratory Health | Obesity & Metabolism | Dental & Oral Health | Eye & Vision Screening | Skin & Hair Health | Senior Citizen Checkups | Mental Health & Wellness | Autoimmune Disorder | Pregnancy & Fertility